Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

119.52
Delayed Data
As of Feb 22
 -0.14 / -0.12%
Today’s Change
102.97
Today|||52-Week Range
126.07
+3.74%
Year-to-Date
Cramer: Buyers for Bristol-Myers Are Few and Far Between
Feb 22 / TheStreet.com - Paid Partner Content
3 Stocks You Dont Have to Babysit
Feb 14 / MotleyFool.com - Paid Partner Content
These 10 stocks dominate the market
Feb 22 / CNNMoney.com
GSK claims new HIV combination therapy will be 'less harmful'
Feb 13 / FT.com - Paid Partner Content
3 Dividend Stocks for 2017
Feb 21 / GuruFocus News - Paid Partner Content
Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More
Feb 13 / Zacks.com - Paid Partner Content
Takeaways and Observations
Feb 21 / TheStreet.com - Paid Partner Content
Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017
Feb 10 / MotleyFool.com - Paid Partner Content
Bristol-Myers Buys Back Shares, Shuffles Board
Feb 21 / TheStreet.com - Paid Partner Content
3 Stocks We'd Buy and Hold for the Next 20 Years
Feb 10 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Alle...
Feb 21 / Zacks.com - Paid Partner Content
3 Trump-Proof Dividend Stocks to Buy Right Now
Feb 09 / MotleyFool.com - Paid Partner Content
3 Stocks to Invest in Big Pharma
Feb 20 / MotleyFool.com - Paid Partner Content
4 Stocks Under $4 That Could Double
Feb 09 / MotleyFool.com - Paid Partner Content
Better Buy: Eli Lilly and Company vs. Johnson & Johnson
Feb 18 / MotleyFool.com - Paid Partner Content
Sanofi points to lower profit for 2017
Feb 08 / FT.com - Paid Partner Content
The Four Key Themes From Q4 Conference Calls
Feb 17 / Investing Channel - Paid Partner Content
Pharma stocks rally on Trump pledge to speed drug approvals
Feb 02 / FT.com - Paid Partner Content
Geron (GERN) Q4 Earnings: What's in Store for the Stock?
Feb 17 / Zacks.com - Paid Partner Content
 Pharma execs tout 'manufacturing jobs' in front of Trump
Jan 31 / CNNMoney.com
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Feb 17 / Zacks.com - Paid Partner Content
CEOs cheat sheet on how to please Trump
Jan 31 / CNNMoney.com
Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
Feb 17 / Zacks.com - Paid Partner Content
Week in Review: January 28
Jan 27 / FT.com - Paid Partner Content
Glg Llc Buys Midstates Petroleum Co, Apple, Johnson & Johnson, Sells Teva Pharmaceuti...
Feb 16 / GuruFocus News - Paid Partner Content
J&J digs deep to claim its $30bn Actelion prize
Jan 26 / FT.com - Paid Partner Content
Hurry Up and Grab Some Johnson & Johnson Before the Stock Bursts Even More
Feb 16 / TheStreet.com - Paid Partner Content
Johnson & Johnson's $30B takeover keeps cash overseas
Jan 26 / CNNMoney.com
How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners
Feb 16 / MotleyFool.com - Paid Partner Content
J&J/Actelion: high pressure sale
Jan 26 / FT.com - Paid Partner Content
Health Care ETF Has Been Ailing
Feb 16 / TheStreet.com - Paid Partner Content
Big day for earnings; $29 billion deal; Dow above 20k
Jan 26 / CNNMoney.com
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb 16 / Zacks.com - Paid Partner Content
Johnson & Johnson buys Swiss biotech company Actelion for $30bn
Jan 26 / FT.com - Paid Partner Content
4 High-Yield Dividend Stocks You Don't Have to Babysit
Feb 15 / MotleyFool.com - Paid Partner Content
J&J disappoints on 2017 forecasts due to strong dollar
Jan 24 / FT.com - Paid Partner Content
Merck (MRK) Halts Late Stage Alzheimer Study; Shares Slip
Feb 15 / Zacks.com - Paid Partner Content
Trump meets the Big 3; Earnings bonanza; Brexit ruling
Jan 24 / CNNMoney.com
No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next De...
Feb 15 / MotleyFool.com - Paid Partner Content